EUVIMEDEUVIMED entdecken
EditorialKommentar

The combination of ALBI and AFP response: A small step forward in HCC

Landon L Chan iD, Stephen L Chan

Liver International · 2023

DOI: 10.1111/liv.15494 ↗

Kurz gefasst

Editorial in der Zeitschrift Liver International, 2023. Verfasst von Landon L Chan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Princess Margaret Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansalpha-FetoproteinsBilirubinSerum AlbuminPrognosisRetrospective Studies

Substanzen

alpha-FetoproteinsBilirubinSerum Albumin

Autor:innen und Institutionen

  • Department of Oncology, Princess Margaret Hospital, Hong Kong, China.
  • Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China.
  • State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, China.

ORCID-Profile: Landon L Chan

Zitieren

APA

Chan, L. L., & Chan, S. L. (2023). The combination of ALBI and AFP response: A small step forward in HCC. Liver International. https://doi.org/10.1111/liv.15494

Vancouver

Chan LL, Chan SL. The combination of ALBI and AFP response: A small step forward in HCC. Liver International. 2023. doi:10.1111/liv.15494

BibTeX
@article{Chan2023,
  author = {Chan, Landon L and Chan, Stephen L},
  title = {The combination of ALBI and AFP response: A small step forward in HCC},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15494}
}
Kostenlos starten →